CAS RN: 6055-19-2 | Product Number: C2236
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
|Purity / Analysis Method||>98.0%(N)|
|Molecular Formula / Molecular Weight||C__7H__1__5Cl__2N__2O__2P·H__2O = 279.1|
|Physical State (20 deg.C)||Solid|
|Store Under Inert Gas||Store under inert gas|
|Condition to Avoid||Light Sensitive,Air Sensitive,Heat Sensitive|
|Related CAS RN||50-18-0|
|Reaxys Registry Number||8167897|
|PubChem Substance ID||125307342|
|Merck Index (14)||2747|
|Appearance||White to Almost white powder to crystal|
|Purity(with Total Nitrogen)||min. 98.0 %(calcd.on anh.substance)|
|Melting point||49.0 to 53.0 °C|
|Water||max. 8.0 %|
|Melting Point||51 °C|
|Solubility in water||Slightly soluble|
|Solubility (very soluble in)||Ethanol,Chloroform|
|Solubility (soluble in)||Ether|
|Hazard Statements||H301 : Toxic if swallowed.
H315 : Causes skin irritation.
H362 : May cause harm to breast-fed children.
H340 : May cause genetic defects.
H350 : May cause cancer.
|Precautionary Statements||P263 : Avoid contact during pregnancy and while nursing.
P260 : Do not breathe dust or mist.
P201 : Obtain special instructions before use.
P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection.
P308 + P313 : IF exposed or concerned: Get medical advice/ attention.
P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth.
Uroprotective effect of pentoxifylline in cyclophosphamide-induced hemorrhagic cystitis in rats
Relevance of the cyclophosphamide-induced cystitis model for pharmacological studies targeting inflammation and pain of the bladder
Effect of intrathecal administration of E-series prostaglandin 1 receptor antagonist in a cyclophosphamide-induced cystitis rat model
Effect of silymarin on bladder overactivity in cyclophosphamide-induced cystitis rat model
A rabbit used as a model for testing hematopoietic tissue transplants
Immunomodulatory effects of moxifloxacin in comparison to ciprofloxacin and G-CSF in a murine model of cyclophosphamide-induced leukopenia
Cyclophosphamide cystitis--identification of acrolein as the causative agent
Cyclophosphamide cystitis in rats: involvement of capsaicin-sensitive primary afferents
Increased excitability of afferent neurons innervating rat urinary bladder after chronic bladder inflammation
Cyclophosphamide cystitis in mice: behavioural characterisation and correlation with bladder inflammation
Cyclophosphamide-induced cystitis in freely-moving conscious rats: behavioral approach to a new model of visceral pain
Comparison of voiding function and nociceptive behavior in two rat models of cystitis induced by cyclophosphamide or acetone
The antiemetic effect of a novel tropisetron patch in anticancer agents-induced kaolin pica model using rats
The anti-cancer drug-induced pica in rats is related to their clinical emetogenic potential
An overview of cyclophosphamide and ifosfamide pharmacology
Cyclophosphamide: Review of its mutagenicity for an assessment of potential germ cell risks
The chemistry of the metabolites of cyclophosphamide
Mechanisms of resistance to the toxicity of cyclophosphamide
Optical resolution studies of cyclophosphamide
Safety Data Sheet (SDS) Search
The requested SDS is not available.
Please check that the Product Number you have entered is correct.
If your information is correct and you are still not able to view the requested SDS, please Contact Us for more information.